Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Recruiting now
Conditions studied: Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Carcinoma, Breast Lobular Carcinoma In Situ, Breast Sclerosing Adenosis
In brief
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.
Key facts
- Study ID
- NCT05178498
- Run by
- Ohio State University Comprehensive Cancer Center
- People needed
- 960
- Starts
- 2023-10-25
- Expected to finish
- 2035-12-31
- Last updated by the study team
- 2026-06-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age >= 18 years
- Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer [BC], known genetic predisposition, personal history of known atypia/breast lobular carcinoma in situ [LCIS], or prior chest wall radiation)
- Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS)
- Able to read and understand English
- Able to provide informed consent
- Must consent to continued follow-up of medical records during the study period
You may not qualify if…
- Prisoners
- Not able to speak and understand English
- Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC
Where it is running
- Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.